Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 20/20 | 0.69 |
| ▸ | SLC5A1 | P13866 | 12/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23075233 | 1.00 | SLC5A2 (0.69) | SLC5A2SLC5A1 | |
| SCHEMBL13866727 | 0.85 | SLC5A2 (0.55) | SLC5A2SLC5A1 | |
| SCHEMBL29366271 | 0.84 | SLC5A2 (0.68) | SLC5A2SLC5A1 | |
| SCHEMBL28936814 | 0.84 | SLC5A2 (0.68) | SLC5A2SLC5A1 | |
| SCHEMBL27709965 | 0.84 | SLC5A2 (0.56) | SLC5A2SLC5A1 | |
| Sergliflozin A SCHEMBL2574820 | 0.82 | SLC5A2 (1.00) | SLC5A2SLC5A1 | |
| Sergliflozin A SCHEMBL23436839 | 0.82 | SLC5A2 (1.00) | SLC5A2SLC5A1 | |
| Sergliflozin A SCHEMBL4361463 | 0.82 | SLC5A2 (1.00) | SLC5A2SLC5A1 | |
| SCHEMBL27709956 | 0.79 | SLC5A2 (0.54) | SLC5A2SLC5A1 | |
| SCHEMBL28712344 | 0.78 | SLC5A2 (0.73) | SLC5A2SLC5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2252289-B1 | COMBINATION THERAPY COMPRISING SGLT INHIBITORS AND DPP4 INHIBITORS | MITSUBISHI TANABE PHARMA CORP (JP) | 2019-10-23 | — | — | EP | disclosed |